No evidence for use of pentoxifylline in acute Kawasaki disease.
Nash
M C
MC
Medical Unit, Institute of Child Health, London, UK.
Wade
A M
AM
D000284:Administration, Oral; D002648:Child; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D010431:Pentoxifylline / Q000627:therapeutic use*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014409:Tumor Necrosis Factor-alpha; D014665:Vasodilator Agents; D010431:Pentoxifylline